The role of BRAFV600E mutation in a cohort of DTC with a long term follow-up is described and discussed

BRAFV600E mutation is an indipendent bad prognostic factor for the out come of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

VIOLA, DAVID;Ugolini, Clara;BIAGINI, AGNESE;GIANNINI, RICCARDO;ROMEI, CRISTINA;MICCOLI, PAOLO;PINCHERA, ALDO;BASOLO, FULVIO;ELISEI, ROSSELLA
2007

Abstract

The role of BRAFV600E mutation in a cohort of DTC with a long term follow-up is described and discussed
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/841035
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact